1376609-32-3

Basic information

• Product Name: (1-benzyl-4-methylpiperidin-4-yl)(methyl)carbamic acid tert-butyl ester
• Synonyms: (1-benzyl-4-methylpiperidin-4-yl)(methyl)carbamic acid tert-butyl ester
• CAS NO: 1376609-32-3
• Molecular Weight: 318.459
• Mol File: 1376609-32-3.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: (1-benzyl-4-methylpiperidin-4-yl)(methyl)carbamic acid tert-butyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: (1-benzyl-4-methylpiperidin-4-yl)(methyl)carbamic acid tert-butyl ester(1376609-32-3)
• EPA Substance Registry System: (1-benzyl-4-methylpiperidin-4-yl)(methyl)carbamic acid tert-butyl ester(1376609-32-3)

Safety Data

• Hazardous Substances Data: 1376609-32-3(Hazardous Substances Data)

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 100-39-0 benzyl bromide 
• 163271-07-6 tert-butyl 1-benzyl-4-methylpiperidin-4-ylcarbamate 
• 163271-08-7 4-tert-butoxycarbonylamino-4-methylpiperidine 

Relevant articles and documents

SUBSTITUTED HETEROCYCLIC INHIBITORS OF PTPN11

The present invention relates to compounds which may be useful as inhibitors of PTPN11 for the treatment or prevention of cancer and other PTP-mediated diseases. Disclosed herein are new compounds and compounds based on pyrazolopyrazines and their applica

1,4 DI SUBSTITUTED PYRROLIDINE - 3 - YL -AMINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF METABOLIC DISORDERS

Therapeutic compounds are disclosed having the general formula (1) that are useful for the treatment of metabolic disorders, including type II diabetes.The compounds have activity as agonists of GPR1 19. Compounds having the stereochemistry of formula (la) may also demonstrate DPP-IV inhibitory activity.